Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Coukos

Showing results (331-340 of 355) with videos related to

Pageof 36
Sort By:
Nature Biotechnology|October 11, 2024
A comprehensive proteogenomic pipeline for neoantigen discovery to advance personalized cancer immunotherapyFlorian Huber, Marion Arnaud, Brian J Stevenson, et al.
Cancer Cell|October 14, 2015
Comprehensive Genomic Characterization of Long Non-coding RNAs across Human CancersXiaohui Yan, Zhongyi Hu, Yi Feng, et al.
Cancer Cell|June 12, 2019
Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid TumorsDenarda Dangaj, Marine Bruand, Alizée J Grimm, et al.
Nature Reviews. Cancer|September 24, 2011
Rethinking ovarian cancer: recommendations for improving outcomesSebastian Vaughan, Jermaine I Coward, Robert C Bast, et al.
Nature|November 28, 2024
Cancer cells impair monocyte-mediated T cell stimulation to evade immunityAnais Elewaut, Guillem Estivill, Felix Bayerl, et al.
Science Translational Medicine|April 13, 2018
Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancerJanos L Tanyi, Sara Bobisse, Eran Ophir, et al.
Nature Communications|June 6, 2023
Neoantigen-specific CD8 T cells with high structural avidity preferentially reside in and eliminate tumorsJulien Schmidt, Johanna Chiffelle, Marta A S Perez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2026
Combinatorial delivery of low-dose radiotherapy and immunotherapy to patients with immune-excluded tumors enhances CD8+ T cell functionalityMaria Ochoa-de-Olza, Nicolas Rayroux, Martina Imbimbo, et al.
Cell Reports|July 21, 2021
Cell-autonomous inflammation of BRCA1-deficient ovarian cancers drives both tumor-intrinsic immunoreactivity and immune resistance via STINGMarine Bruand, David Barras, Marco Mina, et al.
Immunity|September 14, 2024
Tumor-reactive T cell clonotype dynamics underlying clinical response to TIL therapy in melanomaJohanna Chiffelle, David Barras, Rémy Pétremand, et al.
Pageof 36

Showing results (331-340 of 355) with videos related to

Sort By:
Pageof 36
Nature Biotechnology|October 11, 2024
A comprehensive proteogenomic pipeline for neoantigen discovery to advance personalized cancer immunotherapyFlorian Huber, Marion Arnaud, Brian J Stevenson, et al.
Cancer Cell|October 14, 2015
Comprehensive Genomic Characterization of Long Non-coding RNAs across Human CancersXiaohui Yan, Zhongyi Hu, Yi Feng, et al.
Cancer Cell|June 12, 2019
Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid TumorsDenarda Dangaj, Marine Bruand, Alizée J Grimm, et al.
Nature Reviews. Cancer|September 24, 2011
Rethinking ovarian cancer: recommendations for improving outcomesSebastian Vaughan, Jermaine I Coward, Robert C Bast, et al.
Nature|November 28, 2024
Cancer cells impair monocyte-mediated T cell stimulation to evade immunityAnais Elewaut, Guillem Estivill, Felix Bayerl, et al.
Science Translational Medicine|April 13, 2018
Personalized cancer vaccine effectively mobilizes antitumor T cell immunity in ovarian cancerJanos L Tanyi, Sara Bobisse, Eran Ophir, et al.
Nature Communications|June 6, 2023
Neoantigen-specific CD8 T cells with high structural avidity preferentially reside in and eliminate tumorsJulien Schmidt, Johanna Chiffelle, Marta A S Perez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2026
Combinatorial delivery of low-dose radiotherapy and immunotherapy to patients with immune-excluded tumors enhances CD8+ T cell functionalityMaria Ochoa-de-Olza, Nicolas Rayroux, Martina Imbimbo, et al.
Cell Reports|July 21, 2021
Cell-autonomous inflammation of BRCA1-deficient ovarian cancers drives both tumor-intrinsic immunoreactivity and immune resistance via STINGMarine Bruand, David Barras, Marco Mina, et al.
Immunity|September 14, 2024
Tumor-reactive T cell clonotype dynamics underlying clinical response to TIL therapy in melanomaJohanna Chiffelle, David Barras, Rémy Pétremand, et al.
Pageof 36